Premium
Sperm DNA fragmentation abnormalities in men from couples with a history of recurrent miscarriage
Author(s) -
Leach Mikaela,
Aitken Robert J.,
Sacks Gavin
Publication year - 2015
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/ajo.12373
Subject(s) - miscarriage , dna fragmentation , sperm , andrology , fragmentation (computing) , biology , medicine , genetics , pregnancy , ecology , apoptosis , programmed cell death
Background Previous studies have described an association between sperm with DNA damage and a history of recurrent miscarriage ( RM ), although it is not clear whether there is benefit in screening for sperm DNA fragmentation and to what extent DNA fragmentation impacts upon RM . Aims To identify what proportion of couples experiencing RM are affected by DNA fragmentation abnormalities. Materials and Methods In this retrospective study, between 2008 and 2013, couples with a history of recurrent miscarriage (≥3 first trimester miscarriages) were investigated comprehensively for known causes (karyotype, uterine, antiphospholipid syndrome, thrombophilia) and also by semen analysis, including DNA fragmentation [sperm chromatin structure analysis ( SCSA )]. Statistical analysis was performed on SPSS software with significance taken as P < 0.05. Results There were 108 couples with a median sperm DNA fragmentation index ( DFI ) of 9.50%. Normal levels were found in 70.5% of men ( DFI < 15%), 23% had high levels ( DFI 15–30%), and 6.5% had very high levels ( DFI > 30%). Couples with otherwise unexplained recurrent miscarriage had significantly higher DFI than those with other causes identified on routine screening ( P = 0.012). Conclusions In couples experiencing RM , 30% (32/108) of men had sperm with high levels of DNA fragmentation ( DFI > 15%). This may be a contributing factor to the clinical syndrome of RM , and future clinical trials of therapies for these couples are warranted.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom